Edition:
India

Lupin Ltd (LUPN.BO)

LUPN.BO on Bombay Stock Exchange

1,001.25INR
11:15am IST
Change (% chg)

Rs-4.55 (-0.45%)
Prev Close
Rs1,005.80
Open
Rs1,014.90
Day's High
Rs1,014.90
Day's Low
Rs997.05
Volume
32,520
Avg. Vol
181,696
52-wk High
Rs1,572.25
52-wk Low
Rs920.00

Chart for

About

Lupin Limited is a pharmaceutical company. The Company is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world. The Company offers products in the cardiovascular, diabetology, asthma, pediatrics, central... (more)

Overall

Beta: -0.02
Market Cap(Mil.): Rs456,360.31
Shares Outstanding(Mil.): 451.80
Dividend: 7.50
Yield (%): 0.74

Financials

  Industry Sector
P/E (TTM): -- 31.08 16.01
EPS (TTM): -- -- --
ROI: -- 14.35 15.15
ROE: -- 15.64 13.79

BRIEF-India's Lupin gets FDA nod for generic flagyl tablets

* Says Lupin receives FDA approval for generic flagyl tablets

13 Sep 2017

BRIEF-India's Lupin gets U.S. FDA approval for generic vibra-tabs tablet

* Says Lupin receives FDA approval for generic vibra-tabs tablet

11 Sep 2017

BRIEF-Lupin launches generic benicar tablets in the U.S.

* Says lupin launches generic benicar tablets in the U.S. Source text - http://bit.ly/2vXYmmI Further company coverage:

04 Sep 2017

BRIEF-India's Lupin launches generic fosrenol chewable tablets in the U.S.

Aug 31 Lupin Ltd * Launches generic fosrenol chewable tablets in the US Source text - http://bit.ly/2vLFaZ0 Further company coverage:

31 Aug 2017

BUZZ-Indian pharma stocks see relief rally; index up 3 pct

** Shares of Indian pharmaceutical companies such as Cadila Healthcare, Lupin Ltd and Sun Pharmaceutical Industries gain between 4.10 pct and 8.9 pct

24 Aug 2017

BRIEF-Lupin launches generic Seroquel tablets in U.S.‍​

* Says drug used for treatment of schizophrenia, acute manic or mixed episodes in bipolar i disorder‍​ Source text: http://bit.ly/2wndJsS Further company coverage:

23 Aug 2017

BRIEF-Lupin gets EIR from U.S. FDA for Aurangabad inspection

* Says receives EIR from U.S. FDA for Aurangabad, April 2017 inspection

21 Aug 2017

BRIEF-Natco Pharma says co, Lupin get FDA nod for generic lanthanum carbonate chewable tablets‍​

* Says Natco, Lupin get FDA nod for generic lanthanum carbonate chewable tablets‍​

14 Aug 2017

Sun Pharma reports first-quarter loss as generics business suffers

India's largest drugmaker Sun Pharmaceutical Industries Ltd posted a surprise quarterly loss on Friday due to one-off legal costs and pressure over prices in its largest market, the United States, casting a shadow over its growth prospects.

11 Aug 2017

UPDATE 2-India's Sun Pharma reports Q1 loss as generics business suffers

* Expects profit margin to improve in second-half of 2018 (Adds Managing Director comments from conference call)

11 Aug 2017

Earnings vs. Estimates